A Novel Thienopyrimidine Analog, TPH104, Mediates Immunogenic Cell Death in Triple-Negative Breast Cancer Cells

Diwakar Bastihalli Tukaramrao(University of Toledo), Amit K. Tiwari(University of Arkansas for Medical Sciences)

Cancers

April 18, 2021

10.3390/cancers13081954

Cited by 20

Related Papers

Novel Thienopyrimidine Derivative, RP-010, Induces β-Catenin Fragmentation and Is Efficacious against Prostate Cancer Cells

|Cancers|2019|19

Bax/Tubulin/Epithelial-Mesenchymal Pathways Determine the Efficacy of Silybin Analog HM015k in Colorectal Cancer Cell Growth and Metastasis

|Frontiers in Pharmacology|2018|18

Novel Thienopyrimidine-Hydrazinyl Compounds Induce DRP1-Mediated Non-Apoptotic Cell Death in Triple-Negative Breast Cancer Cells

|Cancers|2024|3